000 | 00399nam a2200121Ia 4500 | ||
---|---|---|---|
942 | _cPR | ||
650 | _aFIN-SPL | ||
100 | _aCAROLYN MATHEW (SFMMS1719-0022) | ||
654 | _aSun Pharmaceutical, Ranbaxy, Analysis | ||
245 | _aFundamental Analysis of Sun Pharmaceutical Companypost Merger with Ranbaxy | ||
260 |
_bSt. Francis Institute of Management and Research, Mumbai _cWIN/2019 |
||
546 | _aENGLISH | ||
999 |
_c11273 _d11273 |